Universal tumor cell vaccine (GMCD40L) for the treatment of newly diagnosed glioblastoma. A phase I/II study

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Nov 30 2011
EventNABTT meeting - Tampa, FL.
Duration: Nov 30 2011 → …

Conference

ConferenceNABTT meeting
Period11/30/11 → …

Disciplines

  • Medicine and Health Sciences

Cite this